Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
SHED: Stem cells from human exfoliated deciduous teeth
2003 Standout
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
2002
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
2010
Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?
2013
Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?
2000
Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats
1998
Increased Reactive Oxygen Species Production in the Brain After Repeated Low-Dose Pesticide Paraquat Exposure in Rats. A Comparison with Peripheral Tissues
2010
Myelination of the canine central nervous system by glial cell transplantation: A model for repair of human myelin disease
1997
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
2013
Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
1997
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
2002
Progressive multiple sclerosis: pathology and pathogenesis
2012
Paraquat exposure as an etiological factor of Parkinson's disease
2006
Multipotential Marrow Stromal Cells Transduced to Produce L -DOPA: Engraftment in a Rat Model of Parkinson Disease
1999
Parkinson's disease and pesticides: a toxicological perspective
2008
Transplantation in Parkinson’s Disease
2007
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
1999 Standout
Occupational factors and risk of Parkinson's disease: A population‐based case–control study
2009
Progenitor Cell Biology
1999
The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease
2003
Hallmarks of aging: An expanding universe
2023 Standout
Dopaminergic modulation of motor network dynamics in Parkinson's disease
2015
Parkinson's disease: clinical features and diagnosis
2008 Standout
Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
2002 Standout
[sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
1996
Pesticides and Risk of Parkinson Disease
2005
A Broken α-Helix in Folded α-Synuclein
2003 StandoutNobel
Pesticide Exposure and Self-reported Parkinson's Disease in the Agricultural Health Study
2006
Control of goal-directed and stimulus-driven attention in the brain
2002 Standout
Parkinson's disease
2009 Standout
Rare genetic mutations shed light on the pathogenesis of Parkinson disease
2003
Familial Dementia With Lewy Bodies
2002
The prion hypothesis in Parkinson's disease: Braak to the future
2013
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
The biochemistry of apoptosis
2000 StandoutNature
Mitochondria: In Sickness and in Health
2012 Standout
Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
1994
Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease
2001
Functional Decline in Parkinson Disease
2001
Environmental Risk Factors and Parkinson's Disease: A Metaanalysis
2001
Parkinson's disease
2015 Standout
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
2003
Ubiquitin–proteasome system and Parkinson's disease
2006
Therapy for mitochondrial disorders: Little proof, high research activity, some promise
2011
Protective and Damaging Effects of Stress Mediators
1998 Standout
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
2004
Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease
1994
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
The neuropathology of genetic Parkinson's disease
2012
α-Synuclein: Normal Function and Role in Neurodegenerative Diseases
2004
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
2008
Parkinson's disease and α‐synuclein expression
2011
Intravenous amantadine improves levadopa‐induced dyskinesias: An acute double‐blind placebo‐controlled study
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Neurotoxic in vivo models of Parkinson’s disease
2010
Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson???s Disease
2005
Environmental Factors in Parkinson’s Disease
2002
Autophagy and Aging
2011 Standout
Neuroprotection by the Inhibition of Apoptosis
2000
Transplantation of in vitro‐expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats
2002
Parkinson's Disease
1998 Standout
Alpha-synuclein and neurodegenerative diseases
2001
A Fresh Look at iPS Cells
2009 StandoutNobel
Drosophila DJ-1 Mutants Are Selectively Sensitive to Environmental Toxins Associated with Parkinson’s Disease
2005
Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain
1999 Standout
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report
2008
Multiple Sclerosis
2000 Standout
α-synuclein locus duplication as a cause of familial Parkinson's disease
2004 Standout
Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson???s Disease
2007
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
1999
Contributions of Positron Emission Tomography to elucidating the pathogenesis of Idiopathic Parkinsonism and Dopa Responsive Dystonia
1997
Imaging biomarkers in Parkinson's disease
2011
Assessing coping strategies: A theoretically based approach.
1989 Standout
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein
1995
Solvent exposures and parkinson disease risk in twins
2011
Smoking and Parkinson's disease: Systematic review of prospective studies
2004
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
Impact of Social Environment Characteristics on Neuroendocrine Regulation
1996
Re-emergent tremor of Parkinson's disease
1999
The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease
2003
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
2005
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
2001
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Transplantation of brain cells assembled around a programmable synthetic microenvironment
2001
Neurodegeneration and neuroprotection in Parkinson disease
2004
Mitochondria-Targeted Small Molecule Therapeutics and Probes
2011
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease
1996
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts
1998
Associations of welding and manganese exposure with Parkinson disease
2012
Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum
2007
Rare genetic mutations shed light on the pathogenesis of Parkinson disease
2003
Implantation of Fetal Tissue for the Management of Parkinson??s Disease
1995
Type A Behavior: Epidemiologic Foundations and Public Health Implications
1984
Cigarette smoking and protection from Parkinson's disease
1995
Psychosocial Influences on Mortality after Myocardial Infarction
1984 Standout
Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers
2004 StandoutScience
Stress Hormones: Their Interaction and Regulation
1984 ScienceNobel
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
De novo design of modular protein hydrogels with programmable intra- and extracellular viscoelasticity
2024 StandoutNobel
Multiple Sclerosis
2018 Standout
The future of cloning
1999 StandoutNatureNobel
Neural Stem and Progenitor Cells: A Strategy for Gene Therapy and Brain Repair
1998
Pesticide/Environmental Exposures and Parkinson's Disease in East Texas
2008
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Cell Therapy for Parkinson's Disease: What Next?
2013
Propranolol Medication among Coronary Patients: Relationship to Type a Behavior and Cardiovascular Response
1982
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events
1999
Cell replacement therapies for central nervous system disorders
2000
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
2000 Standout
Neural Science
2000 StandoutNobel
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Mitochondria-Targeted Drugs
2018
Psychological perspectives on the Type A behavior pattern.
1982
Two-component protein-engineered physical hydrogels for cell encapsulation
2009
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
2008
Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream.
1986 StandoutNobel
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination
1999
Third-Generation Biomedical Materials
2002 StandoutScience
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a P arkinson disease patient
2016
Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice
2011 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Regulation of patched by sonic hedgehog in the developing neural tube.
1996 Standout
Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
2001
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Stem Cells in the Central Nervous System
1997 Science
Occupation and risk of parkinsonism: a multicenter case-control study.
2009
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Works of Barry Snow being referenced
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)
1992
A case‐control study of Parkinson's disease in a horticultural region of British Columbia
1994
Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
1999
Hereditary form of parkinsonism—dementia
1998
Positron emission tomographic studies of dopa‐responsive dystonia and early‐onset idiopathic parkinsonism
1993
Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease
1995
A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
2010
Parkinson's disease: A case‐control study of occupational and environmental risk factors
1990
Positron emission tomography in Shy‐Drager syndrome
1990
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
1998
The Effect of Amantadine on Levodopa-induced Dyskinesias in Parkinson's Disease: A Double-blind, Placebo-controlled Study
2000
Parkinsonism induced by solvent abuse
1994
Positron Emission Tomographic Scanning Demonstrates a Presynaptic Dopaminergic Lesion in Lytico-Bodig
1990
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
1997
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
1995
Level of Aspiration in Coronary Prone and Noncoronary Prone Adults
1978
Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease.
1996
Effect of Task Overload Upon Cardiovascular and Plasma Catcholamine Responses in Type A and B Individuals
1980
Parkinsonism caused by petroleum waste ingestion
1994
Effect of Harassment and Competition Upon Cardiovascular and Plasma Catecholamine Responses in Type A and Type B Individuals
1980
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
1994